| 1 | 09:00-09:08 | 病例报告 |
银河肺风暴带来的病例思考 |
|
||||
| 2 | 09:08-09:16 | 病例报告 |
“激素依赖性”发热、弥漫性磨玻璃影1例 |
|
||||
| 3 | 09:16-09:24 | 病例报告 |
肺囊万象,抽丝破局 |
|
||||
| 4 | 09:24-09:32 | 病例报告 |
从“咳黄水”到诊断明确:一例胆道支气管漏的识别与多学科管理 |
|
||||
| 5 | 09:32-09:40 | 病例报告 |
一例以大咯血为首发的特发性含铁血黄素沉着症 |
|
||||
| 6 | 09:40-09:48 | 病例报告 |
一例年轻患者的肺间质纤维化引发的临床思考 |
|
||||
| 7 | 09:48-09:56 | 病例报告 |
雾都魅影:巨噬者之印 |
|
||||
| 8 | 09:56-10:04 | 病例报告 |
双肺弥漫性细小结节伴快速进展呼吸困难1例 |
|
||||
| 9 | 10:04-10:12 | 病例报告 |
失明伴间质性肺炎 |
|
||||
| 10 | 10:12-10:20 | 病例报告 |
弥漫性肺骨化症1例分享 |
|
||||
| 11 | 10:20-10:28 | 病例报告 |
双肺弥漫磨玻璃结节影,RB-ILD合并肺癌一例 |
|
||||
| 12 | 10:28-10:36 | 病例报告 |
IgG4相关ILD1例汇报 |
|
||||
| 13 | 10:36-10:40 | 讨论 |
讨论 |
|||||
| 1 | 10:40-12:00 | 读片会 |
华北地区 |
|
||||||||||
| 2 | 10:40-12:00 | 读片会 |
华东地区 |
|
||||||||||
| 3 | 10:40-12:00 | 读片会 |
华西地区 |
|
||||||||||
| 4 | 10:40-12:00 | 读片会 |
华南地区 |
|
||||||||||
| 1 | 13:00-13:20 | 专题发言 |
间质性肺疾病的诊疗路径 |
|
||||
| 2 | 13:20-13:40 | 专题发言 |
基于冷冻肺活检的间质性肺疾病的病理特征与诊断 |
|
||||
| 3 | 13:40-14:00 | 专题发言 |
间质性肺疾病的肺功能检测与评价 |
|
||||
| 4 | 14:00-14:20 | 专题发言 |
自身抗体谱在结缔组织疾病诊断中的解读 |
|
||||
| 5 | 14:20-14:40 | 专题发言 |
特发性间质性肺炎的HRCT表现 |
|
||||
| 6 | 14:40-15:00 | 专题发言 |
ILD急性加重的糖皮质激素使用新证据 |
|
||||
| 1 | 15:15-15:40 | 专题发言 |
粤港澳大湾区ILD规范化建设进展 |
|
||||
| 2 | 15:40-16:05 | 专题发言 |
肿瘤合并ILD诊疗进展 |
|
||||
| 3 | 16:05-16:30 | 专题发言 |
VATS肺活检与冷冻肺活检在诊断ILD中的优劣分析 |
|
||||
| 4 | 16:30-16:55 | 专题发言 |
病理科医生视角下的ILD |
|
||||
| 5 | 16:55-17:20 | 专题发言 |
器官芯片在肺部疾病中的应用 |
|
||||
| 1 | 15:00-15:20 | 操作演示 |
操作演示1 |
|
||||
| 2 | 15:20-15:40 | 操作演示 |
操作演示2 |
|
||||
| 3 | 15:40-16:00 | 操作演示 |
操作演示3 |
|
||||
| 4 | 16:00-16:20 | 操作演示 |
操作演示4 |
|
||||
| 5 | 16:20-17:00 |
学员动手操作 |
||||||
| 1 | 08:00-08:30 | 致辞 |
致辞 |
|
||||||||||
| 1 | 08:30-09:00 | 大会报告 |
Update on sarcoidosis: what is old, what is new? |
|
||||
| 2 | 09:00-09:30 | 大会报告 |
生物制剂在CTD-ILD中的应用 |
|
||||
| 3 | 09:30-10:00 | 大会报告 |
靶向血管Angiocrine节点的肺纤维化治疗手段 |
|
||||
| 1 | 10:00-10:25 | 大会报告 |
从影像异常到疾病拦截:ILA驱动的ILD早期诊断 |
|
||||
| 2 | 10:25-10:50 | 大会报告 |
IPF全周期管理范式进展:NOT only anti-fibrosis |
|
||||
| 3 | 10:50-11:15 | 大会报告 |
纤维化型ILD的诊疗进展 |
|
||||
| 4 | 11:15-11:40 | 大会报告 |
当ILD遇上肺癌:MDT视角下的治疗矛盾化解 |
|
||||
| 5 | 11:40-12:05 | 大会报告 |
ANCA血管炎相关ILD研究进展 |
|
||||
| 1 | 13:00-13:03 | 壁报发言 |
基于巨噬细胞异质性的肺纤维化发病机制:亚群特异性通路与靶向治疗新策略 |
|
||||
| 2 | 13:00-13:03 | 壁报发言 |
ISM1通过调节脂肪酸代谢减轻肺纤维化 |
|
||||
| 3 | 13:06-13:09 | 壁报发言 |
Research Landscape and Trends in Aging on Interstitial Lung Diseases: A Bibliometric Analysis |
|
||||
| 4 | 13:09-13:12 | 壁报发言 |
Matrix Metalloproteinases levels in induced sputum in IPF and CTD-ILD |
|
||||
| 5 | 13:12-13:15 | 壁报发言 |
A prognostic model of patients with MDA5-positive dermatomyositis-associated interstitial lung disease: a multicenter retrospective cohort study in China |
|
||||
| 6 | 13:15-13:18 | 壁报发言 |
Developing and Validation of a Multimodal-based Machine Learning Model for Diagnosis of Usual Interstitial Pneumonia: a Prospective Multicenter Study |
|
||||
| 7 | 13:18-13:21 | 壁报发言 |
The prevalence and unique clinical features of CPFE among patients with connective tissue disease-associated interstitial lung disease-A retrospective, real-world study |
|
||||
| 8 | 13:21-13:24 | 壁报发言 |
基于炎症-营养学对特发性肺纤维化合并肺癌患者的生存预后分析 |
|
||||
| 9 | 13:24-13:27 | 壁报发言 |
68Ga-FAPI-04 PET/CT in the Evaluation of Fibrosis Activation and Clinical Feature Correlation in Anti-MDA5 Positive Dermatomyositis-Associated Interstitial Lung Disease |
|
||||
| 1 | 14:00-14:15 | 专题发言 |
2024-2025ATS/ERS大会ILD领域新进展 |
|
||||
| 2 | 14:15-14:30 | 专题发言 |
PET-CT在ILD诊疗应用进展 |
|
||||
| 3 | 14:30-14:45 | 专题发言 |
ILD新型诊断工具的开发与临床应用前景 |
|
||||
| 4 | 14:45-15:00 | 专题发言 |
从生物标志物到ILD个体化生存预测 |
|
||||
| 5 | 15:00-15:15 | 专题发言 |
过敏性肺炎的诊疗进展 |
|
||||
| 6 | 15:15-15:20 | 论文发言 |
基于多光子显微成像的胶原定量表征预测肺纤维化进展 |
|
||||
| 7 | 15:20-15:25 | 论文发言 |
SDC1介导TG2核转位激活NF-κB通路促进肺泡上皮细胞损伤与肺纤维化机制研究 |
|
||||
| 8 | 15:25-15:30 | 论文发言 |
Single-Cell Transcriptomics Reveals Dual Role of CD40L+CD4+ T Cells in Immunosuppression and Fibrosis in Idiopathic Pulmonary Fibrosis |
|
||||
| 9 | 15:30-15:35 | 论文发言 |
巴瑞替尼抑制M2型巨噬细胞极化后,miR-126a-3p分泌增多从而缓解RA-ILD |
|
||||
| 10 | 15:35-15:40 | 论文发言 |
ITIH5high巨噬细胞活化成纤维细胞Smad2/3促进肺纤维化 |
|
||||
| 11 | 15:40-15:45 | 论文发言 |
Cholesterol Metabolic Reprogramming Drives the Switch from Pro-inflammatory to Repair Phenotype in Macrophages of Fibrotic Lungs |
|
||||
| 12 | 15:45-16:00 | 讨论 |
讨论 |
|||||
| 1 | 16:00-16:15 | 专题发言 |
基于可治疗特征驱动的ILD动态管理 |
|
||||
| 2 | 16:15-16:30 | 专题发言 |
ILD与共病的管理策略 |
|
||||
| 3 | 16:30-16:45 | 专题发言 |
肺康复治疗在ILD患者中的循证实践路径 |
|
||||
| 4 | 16:45-17:00 | 专题发言 |
抗纤维化在CTD-ILD治疗中的地位 |
|
||||
| 5 | 17:00-17:15 | 专题发言 |
肺移植评估时机的临床决策树构建 |
|
||||
| 6 | 17:15-17:20 | 论文发言 |
NUFIP1 介导的核糖体自噬在特发性肺纤维化发病机制中的作用研究 |
|
||||
| 7 | 17:20-17:25 | 论文发言 |
Carbonic Anhydrase 4 maintains aerocyte identity to attenuate lung fibrosis |
|
||||
| 8 | 17:25-17:30 | 论文发言 |
1,25(OH)2D3 inhibits proliferation and migration of TSC2-/- cells through VDR modulation of the ER-ERK signaling axis |
|
||||
| 9 | 17:30-17:35 | 论文发言 |
天麻素通过激活PINK1/Parkin介导的线粒体自噬缓解肺泡上皮细胞EMT改善肺纤维化的作用与机制研究 |
|
||||
| 10 | 17:35-17:40 | 论文发言 |
AAV-Mediated PRDM16 Gene Therapy Attenuates Pulmonary Fibrosis via PPM1A-Dependent SMAD3 Dephosphorylation in Lung Fibroblasts |
|
||||
| 11 | 17:40-17:45 | 论文发言 |
全基因组CRISPR screen鉴定DTX4通过调控肺泡巨噬细胞胆固醇外排参与肺泡蛋白沉积症发生发展 |
|
||||
| 12 | 17:45-18:00 | 讨论 |
讨论 |
|||||
| 1 | 13:00-13:03 | 壁报发言 |
IL-33/ST2诱导AKT磷酸化调控巨噬细胞与成纤维细胞互作介导肺损伤与纤维化修复的作用机制 |
|
||||
| 2 | 13:03-13:06 | 壁报发言 |
NAT10通过ac4C修饰调控CAMKK1促进肺纤维化的机制研究 |
|
||||
| 3 | 13:06-13:09 | 壁报发言 |
Research progress of single-cell transcriptome sequencing in idiopathic pulmonary fibrosis |
|
||||
| 4 | 13:09-13:12 | 壁报发言 |
靶向抑制BCL-XL清除衰老肌成纤维细胞促上皮细胞转分化的抗肺纤维化机制研究 |
|
||||
| 5 | 13:12-13:15 | 壁报发言 |
Potential biomarkers of idiopathic pulmonary fibrosis: metabonomics driven lipid profiling |
|
||||
| 6 | 13:15-13:18 | 壁报发言 |
Hydroxychloroquine in the Treatment of Adult Pulmonary Fibrosis with Emphysema Associated with SFTPC Mutation: Case Report |
|
||||
| 7 | 13:18-13:21 | 壁报发言 |
特发性炎性肌病相关间质性肺疾病的胸部定量影像的纵向变化分析 |
|
||||
| 8 | 13:21-13:24 | 壁报发言 |
急性加重性间质性肺疾病的流行病学研究进展:发病率、危险因素与预后差异的多维视角 |
|
||||
| 1 | 14:00-14:25 | 专题发言 |
Tweak-Fn14信号介导的巨噬细胞-成纤维细胞互作在肺纤维化中的作用与机制 |
|
||||
| 2 | 14:25-14:50 | 专题发言 |
表观遗传学与肺纤维化的发生 |
|
||||
| 3 | 14:50-15:15 | 专题发言 |
纤维化效应细胞的动态监测与靶向干预研究 |
|
||||
| 4 | 15:15-15:20 | 论文发言 |
BCAA metabolic rewiring controls pulmonary fibrosis through KDM4a-mediated epigenetic remodeling |
|
||||
| 5 | 15:20-15:25 | 论文发言 |
Sivelestat Sodium: A Novel Therapeutic Agent in a Mouse Model of Acute Exacerbation Pulmonary Fibrosis through Multiple Mechanisms |
|
||||
| 6 | 15:25-15:30 | 论文发言 |
Association of Systemic Immune-Inflammation Index and Prognostic Nutritional Index with Tumor Comorbidity in COPD Patients: A Nomogram-Based Predictive Model |
|
||||
| 7 | 15:30-15:35 | 论文发言 |
气体散射介质吸收光谱技术在间质性肺疾病中的研究进展 |
|
||||
| 8 | 15:35-15:40 | 论文发言 |
Artificial-intelligence-driven Airway and Emphysema Quantitation Stratifies Mortality in Patients with Combined Pulmonary Fibrosis and Emphysema: A Multicenter Establishment and Validation |
|
||||
| 9 | 15:40-16:00 | 讨论 |
讨论 |
|||||
| 1 | 16:00-16:25 | 专题发言 |
Targeting FSTL1 for multiple fibrotic diseases |
|
||||
| 2 | 16:25-16:50 | 专题发言 |
尘肺病的免疫机制和转化研究 |
|
||||
| 3 | 16:50-17:15 | 专题发言 |
气道基底干细胞治疗慢性呼吸系统病的研究进展 |
|
||||
| 4 | 17:15-17:20 | 论文发言 |
进展性肺纤维化的临床特征及危险因素分析 |
|
||||
| 5 | 17:20-17:25 | 论文发言 |
结缔组织病相关间质性肺疾病合并侵袭性肺真菌病的临床特征及危险因素分析 |
|
||||
| 6 | 17:25-17:30 | 论文发言 |
Establishment and validation of risk prediction model for pulmonary hypertension associated with interstitial lung disease |
|
||||
| 7 | 17:30-17:35 | 论文发言 |
人工智能在间质性肺病领域的研究热点挖掘与现状研判 |
|
||||
| 8 | 17:35-17:40 | 论文发言 |
基于多模态数据与深度学习的中国多中心特发性肺纤维化患者预后研究 |
|
||||
| 9 | 17:40-18:00 | 讨论 |
讨论 |
|||||
| 1 | 08:00-08:25 | 大会报告 |
间质性肺疾病年度进展 |
|
||||
| 2 | 08:25-08:50 | 大会报告 |
CTD合并RP-ILD诊疗进展 |
|
||||
| 3 | 08:50-09:15 | 大会报告 |
从病例谈间质性肺疾病的中医药治疗 |
|
||||
| 4 | 09:15-09:40 | 大会报告 |
职业肺病与自身免疫的相关性 |
|
||||
| 1 | 09:40-10:05 | 病例报告 |
病例一 |
|
||||
| 2 | 10:05-10:30 | 病例报告 |
病例二 |
|
||||
| 3 | 10:30-10:55 | 病例报告 |
病例三 |
|
||||
| 4 | 10:55-11:20 | 病例报告 |
病例四 |
|
||||
| 5 | 11:20-11:30 | 讨论 |
讨论 |
|||||